Understanding the pharmacology shapes the dosage logic
showed that suppression of microglial activation with minocycline reduced TNF- and IL-1 secretion, promoted endothelial repair, decreased infarct volume and BBB leakage, and improved neurological outcomes (98)
The FDA has confirmed there is no legal basis for compounding pharmacies to use it
Current evidence suggests that BPC-157 is not a weight loss peptide and does not directly burn fat, suppress appetite, or significantly increase metabolism
Longitudinal association of Apolipoprotein E polymorphism with lipid profile, type 2 diabetes and metabolic syndrome: results from a 15 year follow-up study
While this is an effective method, it hasnt been carefully studied in clinical trials (22)